LatanoprostThird Party Manufacturing in India

Latanoprost works by acting as a selective agonist at the prostanoid FP receptor within ocular tissues. It increases the outflow of aqueous humor primarily through the uveoscleral pathway, which directly lowers elevated intraocular pressure. Unlike traditional beta-blockers, it delivers consistent control over pressure levels throughout a 24-hour period with a single daily application. It is highly effective and well-tolerated for long-term pressure management.

Therapeutic Uses

• Open-Angle Glaucoma: Long-term management to lower elevated intraocular pressure and reduce the risk of optic nerve damage.
• Ocular Hypertension: Treatment of elevated intraocular pressure in patients showing intolerance to other pressure-lowering therapies.

Why Manufacturers Choose Latanoprost

Latanoprost third party manufacturing in India represents a high-value category within chronic care ophthalmics due to strong patient compliance and steady market demand. Our partner facilities utilize specialized cold-chain and aseptic filling infrastructure that adheres to strict WHO-GMP guidelines to maintain the stability of this lipid compound. Utilizing these WHO-GMP certified partner networks helps ensure precise formulation assays and helps avoid degradation challenges. This specialized product enables brands to compete effectively in premium anti-glaucoma segments.